Ameritas Investment Partners’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q2 | – | Sell |
-3,530
| Closed | -$605K | – | 3273 |
|
2021
Q1 | $605K | Sell |
3,530
-84
| -2% | -$14.4K | 0.02% | 738 |
|
2020
Q4 | $794K | Buy |
3,614
+366
| +11% | +$80.4K | 0.04% | 634 |
|
2020
Q3 | $539K | Hold |
3,248
| – | – | 0.02% | 701 |
|
2020
Q2 | $371K | Buy |
3,248
+660
| +26% | +$75.4K | 0.02% | 787 |
|
2020
Q1 | $199K | Buy |
2,588
+215
| +9% | +$16.5K | 0.01% | 939 |
|
2019
Q4 | $306K | Buy |
2,373
+108
| +5% | +$13.9K | 0.01% | 881 |
|
2019
Q3 | $176K | Buy |
2,265
+132
| +6% | +$10.3K | 0.01% | 1123 |
|
2019
Q2 | $220K | Buy |
2,133
+366
| +21% | +$37.8K | 0.01% | 1008 |
|
2019
Q1 | $130K | Buy |
1,767
+201
| +13% | +$14.8K | 0.01% | 1311 |
|
2018
Q4 | $66K | Hold |
1,566
| – | – | ﹤0.01% | 1655 |
|
2018
Q3 | $74K | Buy |
1,566
+150
| +11% | +$7.09K | ﹤0.01% | 1750 |
|
2018
Q2 | $70K | Buy |
+1,416
| New | +$70K | ﹤0.01% | 1786 |
|
2017
Q2 | – | Sell |
-893
| Closed | -$5K | – | 3065 |
|
2017
Q1 | $5K | Buy |
+893
| New | +$5K | ﹤0.01% | 2851 |
|